Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Rosiglitazone Maleate and Glimepiride Articles

TZD diabetes drugs to get black box warning

20 August 2007

Reaction to Avandia warnings stronger among internists than endocrinologists

23 July 2007

Actos/Avandia get black box after Congress hears how GSK and FDA handled concerns

18 June 2007

GSK alerts US prescribers to Avandia problems

26 February 2007

GSK's Avandia delays deterioration of glucose control, five-year ADOPT data show

11 December 2006

GlaxoSmithKline sees 2nd-qtr net leap 14% on strong, 11%, sales growth

31 July 2006

Strong data for GSK's Avandaryl

13 June 2006

GlaxoSmithKline's 7% sales growth and 18% EPS rise in line with expectations

13 February 2006

GSK launches Avandaryl in USA

6 February 2006

GlaxoSmithKline's R&D pipeline looks set to drive near-term growth

21 February 2005

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • It's official: "obesity is a disease," says AMA
  • Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
  • Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • It's official: "obesity is a disease," says AMA
  • Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS